Exhibit 31.2

                            CERTIFICATION PURSUANT TO
                                 SECTION 302 of
                         THE SARBANES-OXLEY ACT OF 2002

I, Kenneth J. Zuerblis, certify that:

      1.    I have reviewed this quarterly report on Form 10-Q of Enzon
            Pharmaceuticals, Inc. ("Enzon");

      2.    Based on my knowledge, this quarterly report does not contain any
            untrue statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this report;

      3.    Based on my knowledge, the financial statements, and other financial
            information included in this quarterly report, fairly present in all
            material respects the financial condition, results of operations and
            cash flows of the registrant as of, and for, the periods presented
            in this report;

      4.    The registrant's other certifying officer and I are responsible for
            establishing and maintaining disclosure controls and procedures (as
            defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
            registrant and we have:

                  a.    Designed such disclosure controls and procedures, or
                        caused such disclosure controls and procedures to be
                        designed under our supervision, to ensure that material
                        information relating to the registrant, including its
                        consolidated subsidiaries, is made known to us by others
                        within those entities, particularly during the period in
                        which this quarterly report is being prepared;

                  b.    Evaluated the effectiveness of the registrant's
                        disclosure controls and procedures and presented in this
                        quarterly report our conclusions about the effectiveness
                        of the disclosure and procedures, as of the end of the
                        period covered by this report based on such evaluation;

                  c.    Disclosed in this report any change in the registrant's
                        internal control over financial reporting that occurred
                        during the registrant's most recent fiscal quarter (the
                        registrant's fourth fiscal quarter in the case of an
                        annual report) that has materially affected, or is
                        reasonably likely to materially affect, the registrant's
                        internal control over financial reporting; and

      5.    The registrant's other certifying officer and I have disclosed,
            based on our most recent evaluation of internal control over
            financial reporting, to the registrant's auditors and to the audit
            committee of registrant's board of directors (or persons performing
            the equivalent functions):

                  a.    All significant deficiencies and material weaknesses in
                        the design or operation of internal control over
                        financial reporting which are reasonable likely to
                        adversely affect the registrant's ability to record,
                        process, summarize and report financial information; and

                  b.    Any fraud, whether or not material, that involves
                        management or other employees who have a significant
                        role in the registrant's internal control over financial
                        reporting.


May 10, 2004                            By: /s/ Kenneth J. Zuerblis
                                           ---------------------------
                                           Kenneth J. Zuerblis
                                           Vice President Finance,
                                           Chief Financial Officer
                                           Corporate Secretary
                                           (Principal Financial and
                                           Accounting Officer) and
                                           Corporate Secretary


                                       27